To understand which causes of death are higher in black than white community-dwelling older adults and determine whether differences in baseline risk factors explain racial differences in mortality. DESIGN: Longitudinal cohort study (Health, Aging, and Body Composition Study). SETTING: Pittsburgh, Pennsylvania; and Memphis, Tennessee. PARTICIPANTS: Black and white men and women aged 70 to 79 during recruitment (N=3,075; 48% men, 42% black) followed for a median of 13 years. MEASUREMENTS: A committee of physicians adjudicated cause of death, which was categorized as cardiovascular disease (CVD), stroke, cancer, dementia, pulmonary, infection, kidney, or other causes. Using competing risks regression, we examined whether known risk factors at baseline (demographic characteristics, smoking, body mass index, chronic diseases, physical function, cognition) could explain racial differences in cause-specific mortality risk. RESULTS: During follow-up, 1,991 (65%) participants died. Black participants died at higher rates from cancer (hazard ratio (HR)=1.36, 95% confidence interval (CI) =1.14-1.63), kidney disease (HR=2.09, 95% CI=1.16-3.74), stroke (HR=1.31, 95% CI=0.98-1.76); and CVD (HR=1.16, 95% CI=0.98-1.37). Poorer physical and cognitive performance at baseline among black participants explained most of the racial difference in risks of dying from kidney disease, stroke, and CVD but not cancer. When examining types of cancer deaths, black participants died at higher rates from multiple myeloma, pancreatic cancer, and prostate cancer, which baseline risk factors did not explain either. CONCLUSION: Factors contributing to poorer physical and cognitive performance in similarly aged black men and women could be targets to reduce excess mortality from CVD, stroke, and kidney disease. More work is needed to identify factors contributing to cancer mortality disparities. J Am Geriatr Soc 66:1980-1986, 2018. Key words: cause-specific mortality; racial differences; African Americans I n the United States, black individuals have a higher mortality rate than white individuals.
I
n the United States, black individuals have a higher mortality rate than white individuals. 1 At ages 70 to 79, blacks die at a 23% higher rate than whites. 1, 2 The racial gap in life expectancy narrows with age, 3 but even at age 70, black men and women live an average of 1.1 and 0.6 years less than white men and women, respectively. The racial difference in mortality may be due to known risk factors that are more prevalent in black individuals. For example, black Americans have a higher prevalence of diabetes, 4 obesity, 5 hypertension, 6 and physical inactivity 7 than white Americans, and black men have a higher prevalence of smoking than white men. 8 To inform points of intervention to reduce excess mortality in black older adults, evidence is needed to clarify whether differences in known risk factors between black and white older adults can account for racial disparities in mortality.
The Health, Aging, and Body Composition (Health ABC) Study followed a cohort of community-dwelling older black and white men and women. Such a cohort can further our understanding of potential reasons for racial differences in mortality because of its long-term follow-up, substantial proportion of black participants, and detailed baseline interview and examination. It was previously reported that black older adults from the Health ABC Study died at higher rates from coronary heart disease and cancer; differences in baseline risk factors could only explain the racial difference in risk of coronary heart disease mortality. 9 A limitation of this report was that racial differences in mortality due to causes other than heart disease and cancer were not examined because of the limited number of deaths at the time of analysis. Thus, there remains a need to continue this work by examining racial differences in multiple causes of death, in addition to heart disease and cancer, especially because U.S. black older adults die at a higher rate from almost all leading causes of death. 1, 2 The Health ABC Study has a 17.4-year maximum follow-up, and the number of adjudicated deaths has more than tripled since the previous study. 9 Longer follow-up and larger number of deaths allow for greater power to detect racial differences in mortality due to multiple causes, as well as for greater specificity for certain types of cancer deaths. Thus, we sought to examine whether there are racial differences in deaths due to cardiovascular disease (CVD), stroke, cancer, dementia, pulmonary disease, infections, kidney disease, and other causes between black and white older adults from the Health ABC Study and to determine whether differences in measured baseline risk factors could explain any racial differences in mortality due to specific causes.
METHODS

The Health ABC Study
The Health ABC Study is a prospective cohort of 3,075 black and white men and women in Pittsburgh, Pennsylvania, and Memphis, Tennessee, designed to characterize body composition, health, and incident functional limitation. White participants were recruited from a random sample of Medicare beneficiaries, and all age-eligible black residents were recruited. Eligible participants were aged 70 to 79 during recruitment (1997-98) and selfreported no difficulty walking one-quarter of a mile, climbing 10 steps, or with basic activities of daily living. Those who had active cancer treatment in the previous 3 years or were planning to move from the area within the next 3 years were ineligible. 10 The protocol was approved by each field center's institutional review board, and all participants provided written informed consent.
Potential confounders of association between race and mortality
Sociodemographic factors, including date of birth, sex, race (self-reported as black or white), education, marital status, income, and health insurance, as well as smoking status and history or presence of chronic conditions, were assessed in an interview. History or presence of congestive heart failure, cerebrovascular disease, cancer, hypertension, and diabetes were based on self-report of a physician diagnosis. Hypertension and diabetes were confirmed according to medication use. Cognitive performance was measured using the Digit Symbol Substitution Task (DSST). 11 Gait speed was average speed over 20 m.
Mortality
Participants were contacted every 6 months for a median follow-up of 13.1 years. Deaths were identified in obituaries and proxy interviews. A committee of physicians reviewed all medical records, proxy interviews, and death certificates to assign underlying cause of death. For analyses, cause of death was categorized as 12 CVD, stroke, cancer, dementia, pulmonary disease, infection, kidney disease, or other. CVD mortality included deaths from: atherosclerotic CVD, nonatherosclerotic CVD, and other nonstroke CVD. Deaths categorized as other included liver failure, gastrointestinal disease, trauma, amyotrophic lateral sclerosis, Parkinson's disease, epilepsy, metabolic disease, amyloidosis, hip fracture, failure to thrive, myelodysplastic syndrome, and other musculoskeletal diseases.
Statistical analysis
Means with standard deviations or frequencies with percentages were used to describe differences according to race and sex using analysis of variance and chi-square tests. The Kaplan-Meier overall survival curve was plotted according to race and sex. Participants alive at the time of analysis were censored at their last interview date. Cause-specific mortality risk among black and white participants was compared using the Fine and Gray competing risks model to adjust for deaths from other causes. 13 Causes of death with a racial difference in risk at a .10 significance level were plotted using the cumulative incidence function and further examined to determine whether differences in baseline risk factors explained racial differences in risk. We examined a large number of baseline risk factors to determine whether they could further explain racial differences in cause-specific mortality, although further adjustment resulted in a similar amount of attenuation to what was presented here. For comparability, the risk factors presented are similar to previous work in the Cardiovascular Health Study. 12 For causes of death that had a significant racial difference in risk, we compared the estimated risk for black versus white participants, adjusting for age, sex, and study site (Model 1); education, body mass index (BMI), and smoking pack-years (Model 2); and chronic diseases, gait speed, or the DSST (Models 3a-c). A fully adjusted model was also examined (Model 4). Percentage attenuation quantified the extent to which baseline risk factors explained racial differences in cause-specific mortality.
Complete data were available for 2,599 (85%) participants. Multiple imputation was used to replace missing measurements using available information on age, sex, race, marital status, supplemental health insurance, income, pulmonary function, and physical and cognitive performance. The average of 5 imputed values replaced missing measurements for education (0.3%), smoking pack-years (1%), gait speed (13%), and DSST (1%). Consistent results were found using complete case analyses and analyses with imputed values.
RESULTS
Participants had an average age of 74; 48% were men, and 42% were black (Table 1) . During follow-up, 1,991 (65%) participants died. Median survival was 10.6 years (95% confidence interval (CI)=10.0-11.5 years) for black men, 12.8 years (95% CI=12.4-13.4 years) for white men, 13.4 years (95% CI=12.6-14.6 years) for black women, and 15.3 years (95% CI=14.8-16.2 years) for white women ( Figure 1 ). More than half of the deaths were due to CVD and cancer (Table 2) . Few participants died from pulmonary disease, infection, and kidney disease.
Black participants had higher risks of dying from CVD, stroke, kidney disease, and cancer, adjusting for age, sex, and site (Table 3 ). There were no differences in risk of dying from dementia (HR=1.07, 95% CI=0.85-1.35, p=.56), pulmonary diseases (HR=0.81, 95% CI=0.51-1.27, p=.35), infection (HR=0.95, 95% CI=0.60-1.5, p=.84), or 'other' causes (HR=0.92, 95% CI=0.71-1.2, p=.51) between black and white participants, adjusting for age, sex, and site. When examining the cumulative incidence of deaths from CVD, stroke, cancer, or kidney disease (Figure 2 ), it appeared that there may be race-specific differences according to sex, although there were no significant interactions between race and sex (p>.50). Thus, black men and women and white men and women were examined as black and white participants in competing risks models, adjusting for sex. Although not a focus here, women were at higher risk of dying from dementia than men (HR=1.61, 95% CI=1.27-2.03); p<.001), adjusting for age, race, and site, which the fact that women live longer on average may explain. For example, one-quarter of the dementia deaths occurred after age 90 (mean age at dementia death 87), and a larger proportion (57%) of participants who were still alive at age 90 and thus still at risk for dying from dementia were female (Fisher exact test p=.003). Table 3 displays how the black versus white risk of dying from a specific cause of death changes after adjusting for baseline risk factors. Black participants had a 16% higher risk of dying from CVD than white participants, adjusting for age, sex, and site (Model 1). Further adjusting for education, BMI, and smoking pack-years attenuated the racial difference in CVD mortality risk by 44% (Model 2). In the fully adjusted model, the higher risk of dying from CVD in black participants was completely attenuated (Model 4).
CVD mortality
Stroke mortality
Black participants had a 31% higher risk of dying from stroke than white participants, adjusting for age, sex, and site (Model 1). Further adjusting for education, BMI, and smoking pack-years strengthened the association between race and stroke mortality (Model 2). In the fully adjusted model, the racial difference in stroke mortality risk was attenuated by 81% (Model 4), with adjustment for the DSST explaining much of the difference.
Kidney disease mortality
Black participants had more than twice the risk of dying from kidney disease than white participants, adjusting for age, sex, and site (Model 1). Further adjusting for education, BMI, and smoking pack-years minimally attenuated the racial difference (Model 2). In the fully adjusted model, the higher kidney disease mortality risk in black participants was attenuated by 25% (Model 4), with adjustment for gait speed explaining much of the racial difference.
Cancer mortality
Black participants had a 36% higher risk of dying from cancer than white participants, adjusting for age, sex, and site (Model 1). Further adjusting for education, BMI, and smoking pack-years strengthened the racial difference in cancer mortality (Model 2). Additionally adjusting for chronic conditions, DSST, and gait speed also strengthened the association between race and cancer mortality (Model 4). Adding marital status, supplemental health insurance, and income to the fully adjusted model attenuated the higher cancer mortality risk in black participants by 23%, although they still had a significantly higher risk of death from cancer (HR=1.40, 95% CI=1.11-1.76, P=.005).
Specific type of cancer mortality
Of the 490 participants who died from cancer, most died from lung cancer (24%; Supplementary Tables S1, S2), followed by prostate cancer in men (16%) and breast cancer in women (12%). Despite the small numbers, black participants had 4.13 times the risk of dying from multiple myeloma (95% CI=1.78-9.61, P=.001) and an 82% higher risk of dying from pancreatic cancer (95% CI=0.99-3.35, P=.06) than white participants, adjusting for age, sex, and site. Black men also had a 67% higher risk of dying from prostate cancer than white men (95% CI=0.95-2.97, P=.08), adjusting for age and site. BMI, smoking packyears, education, chronic diseases, physical and cognitive performance, and markers of socioeconomic status did not explain the racial differences in risk of dying from multiple myeloma, pancreatic cancer, and prostate cancer.
DISCUSSION
Black participants in the Health ABC Study had higher risks of dying from cancer, kidney disease, stroke, and CVD than white participants. Poorer baseline physical and cognitive performance in black participants explained most of the racial differences in mortality due to kidney disease, stroke, and CVD but not cancer mortality. One potential explanation for why the racial difference in cancer mortality was not explained is that different types of cancers have different etiologies, making for a complicated outcome when all are grouped together. Despite small numbers, we addressed this by examining types of cancer deaths and found that black participants had higher risks of dying from multiple myeloma and pancreatic cancer and that black men had a higher risk of dying from prostate cancer, all of which persisted after adjusting for baseline risk factors. This racial difference was also reflected in the U.S. population. The incidence and mortality of multiple myeloma are more than 2 times as great in black as in white Americans.
14 Similarly, the incidence and mortality of pancreatic cancer are 24% higher in black than white Americans 14 and U.S. black men have a 67% higher incidence of prostate cancer and more than twice the mortality than white men. 15 Given that there is no screening for multiple myeloma or pancreatic cancer and that the incidence and mortality for multiple myeloma, pancreatic cancer, and prostate cancer are higher in black than white Americans, it is unlikely that socioeconomic factors and health insurance explain these racial disparities. Some have suggested that biological factors explain these racial differences in types of cancer deaths. [15] [16] [17] Despite the higher rate of cancer mortality in black participants, white participants had a higher prevalence of cancer at baseline. History or presence of diseases was determined according to self-report of a physician diagnosis, and an ineligibility criterion was active cancer treatment in the past 3 years. Thus, participants who self-reported a history of cancer would have had to have been in remission for at least 3 years. In the United States, black individuals have the highest mortality and shortest survival for most cancers. 18 Thus, it is likely that the higher prevalence of cancer at baseline in white participants was due to survivor bias.
In this cohort, black men and women had worse average gait speed and DSST scores. The disadvantage in physical and cognitive performance explained racial differences in risk of dying from CVD, stroke, and kidney disease most prominently. Performance measures such as these are wellestablished mortality risk factors in older adults; 12, 19, 20 of 825 phenotypic and genetic measures in the Health ABC Study, the DSST and physical performance measures were among the top 10 best predictors of death. 19 Examining an older adult's physical and cognitive performance is often the best measure of overall health, representing the life-long effect of risk factors, such as severity and duration of diseases and interactions of multiple chronic conditions, 21 but physical and cognitive performance are only intermediate markers. Previous work in the Health ABC Study found that older age, black race, low education and literacy, current smoking, and not participating in moderate to vigorous exercise were associated with a higher odds of cognitive decline 22 , whereas risk factors for faster decline in gait speed were female sex, black race, higher BMI, limited knee strength, and low physical activity level. 23 Other work in the Health ABC Study found that indicators of socioeconomic status, such as literacy, education, income, and owning a house, partially attenuated the associations between black race and lower average baseline cognitive and physical performance 24, 25 . Thus, less lifetime learning, financial inadequacy, and unhealthy lifestyles may be underlying risk factors contributing to decline in physical and cognitive performance as pathways to higher mortality from CVD, stroke, and kidney disease in black Health ABC participants, although these previous analyses only partly explain higher risks of physical and cognitive functional impairment in blacks in this cohort.
Baseline risk factors that attenuated the racial difference in mortality risk differed according to cause of death. For example, adjusting for education, BMI, and smoking attenuated the racial difference in CVD mortality by 50% but explained minimal amounts of the racial difference in deaths from kidney disease, cancer, and stroke. Others have noted that race-related mortality risk factors differ according to cause of death. 9, 26 There are also few common risk factors for all causes of death in older adults. 12 Thus, to understand racial disparities in mortality, analyses need to be focused on cause-specific mortality, especially because CVD mortality heavily weights all-cause mortality.
Although not a focus of this report, women had a higher risk of dying only from dementia, which is related in part to their older age at death than men. However, there was no difference in dementia mortality according to race. In the U.S. population, black Americans have a higher prevalence of Alzheimer's disease, 27 although they do not have higher mortality from Alzheimer's disease than white Americans. 28 This is probably because of competing risks of death, such as from CVD, which occur at younger average ages than dementia deaths. Consistent with this, black Health ABC participants died at a higher rate from CVD and died at a younger average age than white participants.
A limitation of this study was the small number of deaths from pulmonary disease, infection, and specific types of cancer. If there had been more deaths from these causes, we might have identified more racial differences. Other limitations included lack of information on types of cancer death and early-life exposures that might better explain racial differences in mortality. Strengths of this study included the large number of black older adults, allowing for an examination of black-white differences; the wellcharacterized cohort, enabling assessment of how multiple baseline risk factors attenuate racial differences in mortality; and the complete data on and adjudication of cause of death by a committee of physicians.
Although all Health ABC participants were recruited to be nondisabled, black participants had a higher mortality rate. Gait speed and the DSST appeared to be meaningful markers of this health disparity. Factors contributing to worse physical and cognitive performance, such as unhealthy lifestyles, financial inadequacy, and lower cognitive reserve, may be common targets for a multifactorial intervention to reduce excess mortality due to CVD, stroke, and kidney disease in black men and women aged 70 to 79. However, the relative disadvantage at baseline among black participants did not explain their higher risk of cancer mortality. Future work is needed to understand how to reduce disparities in cancer mortality, specifically from multiple myeloma, pancreatic cancer, and prostate cancer in black adults aged 70 to 79.
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